Biopharmaceutical CMO & CRO Market Analysis By Source (Mammalian, Non-mammalian), By Service Type (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2014 - 2025

  • ID: 4375440
  • Report
  • 210 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • AbbVie, Inc.
  • BIOMEVA GmbH
  • CELONIC AG
  • DPx
  • JRS PHARMA
  • Patheon
  • MORE
The global biopharmaceutical CMO & CRO (contract manufacturing & research) market is expected to reach USD 37.8 billion by 2025, according to this new report. Healthy outlook of biopharmaceuticals and consequent growth in biopharmaceutical pipelines has resulted into lack of adequate capacity and budget constraints. These factors have convinced many traditional drug developers to take advantage of cost-saving benefits associated with contract services. Traditional biopharmaceutical players are observed to choose outsourcing biopharmaceutical manufacturing rather than making an investment of expensive capital in production equipment and hiring skilled labor.

Significant improvement in the services offered by this CMOs/CROs in context to maturity of complex technology is spurring the adoption of these services. In addition, wide acceptance of single-use technology within CMOs/CROs has significantly transformed the CMOs/CROs landscape by enhancing their capabilities and enabling them to develop products at low operating costs.

Outsourcing services are observed to play critical role in overcoming trade barriers for firms. It enables them to make footprints in foreign market where government regulates to secure local employment through domestic production. Furthermore, as a result of growing demand for these services, smaller companies have also begun to expand their non-GMP facilities.

Further key findings from the report suggest:
- Mammalian cell line-based bioproduction system dominated the share in 2016 in terms of revenue generation
- This can be attributed to the presence of substantial number of mammalian-based manufacturing platforms offered by market leaders such as Lonza, Samsung BioLogics, WuXi Biologics
- CMOs are providing wide range of services for entire chain of biopharmaceutical manufacturing process, consequently held the largest share
- Growing R&D investment in bioproduction is the high impact rendering factor for the growth of CROs
- Robust biologics pipeline and high production cost of biologics have contributed to the largest share of biologics outsourcing
- Monoclonal antibodies accounted for significant share in 2016 owing to the huge success rate of MAbs for disease treatment
- North America is home to large number of biopharmaceutical manufacturing entities, which in turn, have resulted into large share of this region
- Being a lower wage country, China and India are expected to be fastest growing regional market
- Several global companies are translocating their business to Asia Pacific owing to low manufacturing costs in Asian countries
- Boehringer Ingelheim GmbH, Lonza, Samsung BioLogics, Patheon, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. are some of the major companies operating in this space

* PLEASE NOTE: This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie, Inc.
  • BIOMEVA GmbH
  • CELONIC AG
  • DPx
  • JRS PHARMA
  • Patheon
  • MORE
1. Research Methodology
1.1. Information Procurement
1.1.1. Purchased Database
1.1.2. Internal Database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Approaches for Market Estimation
1.4.1. Approach 1: Commodity Flow & Bottom Up Approach
1.4.2. Approach 2: Top Down and Parent Market Analysis

2. Executive Summary
2.1 Market Snapshot

3. Market Variables, Trends & Scope
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Rising investment by CMOs for capacity expansion
3.1.1.2 Commercial success of biopharmaceuticals and consequent increased demand for the biopharmaceuticals
3.1.1.2.1 Notable growth of biologics
3.1.1.3 Robust biopharmaceuticals pipeline
3.1.1.4 Cost and time saving benefits offered by contract services
3.1.2 Market restraint analysis
3.1.2.1 Limited outsourcing amongst well-stablished biopharmaceutical manufacturer
3.2 Penetration &Growth Prospect Mapping For Contract Manufacturing Service, 2016
3.3 Biopharmaceuticals CMO & CRO-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
3.5 Customer Relationship Management In Contract Manufacturing
3.5.1 Selection process of CMO
3.5.2 Operations and quality oversight of CMOs
3.6 Trends In Biopharmaceutical Industry
3.7 R&D Landscape Of Biopharmaceuticals
3.8 Biopharmaceutical CMOs/CROs Opportunity Analysis

4. Biopharmaceuticals CMO & CRO Market: Source Estimates & Trend Analysis
4.1 Global Biopharmaceuticals CMO & CRO Market: Source Movement Analysis
4.2 Mammalian Source
4.2.1 Global mammalian source market, 2014 - 2025 (USD Million)
4.3 Non-mammalian Source
4.3.1 Global mammalian source market, 2014 - 2025 (USD Million)

5. Biopharmaceuticals CMO & CRO Market: Service Type Estimates & Trend Analysis
5.1 Global Biopharmaceuticals CMO & CRO Market: Service Type Movement Analysis
5.2 Contract Manufacturing
5.2.1 Global contract manufacturing market, 2014 - 2025 (USD Million)
5.2.2 Process development
5.2.2.1 Global process development market, 2014 - 2025 (USD Million)
5.2.2.2 Downstream processing
5.2.2.2.1 Global downstream processing market, 2014 - 2025 (USD Million)
5.2.2.3 Upstream processing
5.2.2.3.1 Global upstream processing market, 2014 - 2025 (USD Million)
5.2.3 Fill & finish operations
5.2.3.1 Global fill & finish operations market, 2014 - 2025 (USD Million)
5.2.4 Analytical & QC testing
5.2.4.1 Global analytical & QC testing market, 2014 - 2025 (USD Million)
5.2.5 Packaging
5.2.5.1 Global contract packaging market, 2014 - 2025 (USD Million)
5.3 Contract Research
5.3.1 Global contract research market, 2014 - 2025 (USD Million)
5.3.2 Oncology
5.3.2.1 Global oncology market, 2014 - 2025 (USD Million)
5.3.3 Inflammation & immunology
5.3.3.1 Global inflammation & immunology market, 2014 - 2025 (USD Million)
5.3.4 Cardiology
5.3.4.1 Global cardiology market, 2014 - 2025 (USD Million)
5.3.5 Neuroscience
5.3.5.1 Global neuroscience market, 2014 - 2025 (USD Million)
5.3.6 Others
5.3.6.1 Global other CRO services market, 2014 - 2025 (USD Million)

6. Biopharmaceuticals CMO & CRO Market: Product Estimates & Trend Analysis
6.1 Global Biopharmaceuticals CMO & CRO Market: Product Movement Analysis
6.2 Biologics
6.2.1 Global biologics market, 2014 - 2025 (USD Million)
6.2.2 Monoclonal Antibodies
6.2.2.1 Global monoclonal antibodies market, 2014 - 2025 (USD Million)
6.2.3 Recombinant proteins
6.2.3.1 Global recombinant proteins market, 2014 - 2025 (USD Million)
6.2.4 Vaccines
6.2.4.1 Global vaccines market, 2014 - 2025 (USD Million)
6.3 Antisense, RNAi, & molecular therapy
6.3.1 Global antisense, RNAi, &molecular therapy market, 2014 - 2025 (USD Million)
6.3.2 Others
6.3.2.1 Global other product market, 2014 - 2025 (USD Million)
6.4 Biosimilars
6.4.1 Global biosimilars market, 2014 - 2025 (USD Million)

7. Biopharmaceuticals CMO & CRO Market: Regional Estimates & Trend Analysis, by Service, Source, & Product
7.1 Biopharmaceuticals CMO & CRO Market Share By Region, 2016 & 2025
7.2 North America
7.2.1 North America Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Germany biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.3.3 France
7.3.3.1 France biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.4.2 China
7.4.2.1 China Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.4.3 India
7.4.3.1 India Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Latin America biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Middle East & Africa biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)

8. Competitive Landscape
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Boehringer Ingelheim GmbH
8.3.1.1 Company overview
8.3.1.2 Financial performance
8.3.1.3 Product benchmarking
8.3.1.4 Strategic initiatives
8.3.2 LONZA
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 Inno Biologics Sdn Bhd
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.4 Rentschler Biotechnologie GmbH
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 JRS PHARMA
8.3.5.1 Company overview
8.3.5.1.1 CELONIC AG
8.3.5.2 Financial performance
8.3.5.2.1 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 BIOMEVA GmbH
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 ProBioGen
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 TOYOBO CO., LTD.
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.10 Samsung BioLogics
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 Patheon
8.3.11.1 Company overview
8.3.11.1.1 DPx
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives
8.3.12 CMC Biologics
8.3.12.1 Company overview
8.3.12.2 Financial performance
8.3.12.3 Product benchmarking
8.3.12.4 Strategic initiatives
8.3.13 Binex Co., Ltd.
8.3.13.1 Company overview
8.3.13.2 Financial performance
8.3.13.3 Product benchmarking
8.3.14 WuXi Biologics
8.3.14.1 Company overview
8.3.14.2 Financial performance
8.3.14.3 Product benchmarking
8.3.15 AbbVie, Inc.
8.3.15.1 Company overview
8.3.15.2 Financial performance
8.3.15.3 Product benchmarking
8.3.15.4 Strategic initiatives

List of Tables

Table 1 2015 pipeline of biologics
Table 2 Annual outsourcing budget in 2012
Table 3 Some commercially available biopharmaceuticals and biologics produced using mammalian cell lines
Table 4 Some commercially available biopharmaceuticals and biologics produced using mammalian cell lines
Table 5 Some biopharmaceuticals produced using S. cerevisiae
Table 6 Some commercially available biopharmaceuticals and biologics produced using microbial cell lines
Table 7 Global sales of top biologics in 2014
Table 8 Some commercially available monoclonal antibody products
Table 9 Number of MAbs products by indication area, 2015
Table 10 Time and budget requirement for different stages of vaccine development
Table 11 North America biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 12 North America biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 13 North America biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 14 North America biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 15 North America biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 16 North America biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 17 North America biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 18 North America biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 19 North America biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 20 North America biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 21 North America biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 22 North America biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 23 North America biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 24 North America biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 25 U.S. biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 26 U.S. biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 27 U.S. biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 28 U.S. biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 29 U.S. biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 30 U.S. biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 31 U.S. biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 32 U.S. biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 33 U.S. biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 34 U.S. biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 35 U.S. biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 36 U.S. biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 37 U.S. biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 38 U.S. biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 39 Canada biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 40 Canada biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 41 Canada biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 42 Canada biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 43 Canada biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 44 Canada biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 45 Canada biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 46 Canada biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 47 Canada biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 48 Canada biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 49 Canada biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 50 Canada biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 51 Canada biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 52 Canada biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 53 Europe biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 54 Europe biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 55 Europe biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 56 Europe biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 57 Europe biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 58 Europe biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 59 Europe biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 60 Europe biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 61 Europe biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 62 Europe biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 63 Europe biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 64 Europe biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 65 Europe biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 66 Europe biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 67 Germany biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 68 Germany biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 69 Germany biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 70 Germany biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 71 Germany biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 72 Germany biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 73 Germany biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 74 Germany biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 75 Germany biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 76 Germany biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 77 Germany biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 78 Germany biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 79 Germany biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 80 Germany biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 81 France biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 82 France biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 83 France biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 84 France biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 85 France biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 86 France biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 87 France biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 88 France biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 89 France biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 90 France biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 91 France biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 92 France biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 93 France biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 94 France biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 95 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 96 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 97 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 98 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 99 Asia Pacific biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 100 Asia Pacific biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 101 Asia Pacific biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 102 Asia Pacific biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 103 Asia Pacific biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 104 Asia Pacific biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 105 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 106 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 107 Asia Pacific biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 108 Asia Pacific biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 109 China biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 110 China biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 111 China biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 112 China biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 113 China biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 114 China biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 115 China biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 116 China biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 117 China biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 118 China biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 119 China biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 120 China biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 121 China biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 122 China biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 123 India biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 124 India biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 125 India biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 126 India biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 127 India biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 128 India biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 129 India biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 130 India biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 131 India biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 132 India biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 133 India biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 134 India biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 135 India biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 136 India biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 137 Latin America biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 138 Latin America biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 139 Latin America biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 140 Latin America biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 141 Latin America biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 142 Latin America biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 143 Latin America biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 144 Latin America biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 145 Latin America biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 146 Latin America biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 147 Latin America biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 148 Latin America biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 149 Latin America biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 150 Latin America biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 151 Brazil biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 152 Brazil biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 153 Brazil biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 154 Brazil biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 155 Brazil biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 156 Brazil biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 157 Brazil biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 158 Brazil biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 159 Brazil biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 160 Brazil biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 161 Brazil biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 162 Brazil biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 163 Brazil biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 164 Brazil biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 165 MEA biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 166 MEA biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 167 MEA biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 168 MEA biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 169 MEA biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 170 MEA biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 171 MEA biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 172 MEA biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 173 MEA biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 174 MEA biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 175 MEA biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 176 MEA biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 177 MEA biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 178 MEA biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 179 South Africa biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2016 (USD Million)
Table 180 South Africa biopharmaceuticals CMO & CRO market forecasts, by source, 2016 - 2025 (USD Million)
Table 181 South Africa biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 182 South Africa biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 183 South Africa biopharmaceuticals contract manufacturing market estimates, by service, 2014 - 2016 (USD Million)
Table 184 South Africa biopharmaceuticals contract manufacturing market forecasts, by service, 2017 - 2025 (USD Million)
Table 185 South Africa biopharmaceuticals process development market estimates, by service, 2014 - 2016 (USD Million)
Table 186 South Africa biopharmaceuticals process development market forecasts, by service, 2017 - 2025 (USD Million)
Table 187 South Africa biopharmaceuticals contract research market estimates, by service, 2014 - 2016 (USD Million)
Table 188 South Africa biopharmaceuticals contract research market forecasts, by service, 2017 - 2025 (USD Million)
Table 189 South Africa biopharmaceuticals CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 190 South Africa biopharmaceuticals CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)
Table 191 South Africa biologics CMO & CRO market estimates, by service, 2014 - 2016 (USD Million)
Table 192 South Africa biologics CMO & CRO market forecasts, by service, 2017 - 2025 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Cumulative success rate comparison of biologics with small molecules over time
Figure 12 Number of biologics investigational new drugs, 2005-2015
Figure 13 Number of Reference Products by U.S. Biosimilars Launchable Dates
Figure 14 Market restraint relevance analysis (Current & future impact)
Figure 15 Risk associated with outsourcing services
Figure 16 Penetration & growth prospect mapping for contract manufacturing service, 2016
Figure 17 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 18 Porter’s Five Forces Analysis
Figure 19 CMO selection process
Figure 20 Trends in biopharmaceutical industry
Figure 21 R&D process of biopharmaceutical development
Figure 22 Development phases where outsourcing partners are engaged
Figure 23 Global Biopharmaceuticals CMO & CRO market: Source outlook key takeaways
Figure 24 Global Biopharmaceuticals CMO & CRO market: Source movement a
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Boehringer Ingelheim GmbH
  • LONZA
  • Inno Biologics Sdn Bhd
  • Rentschler Biotechnologie GmbH
  • JRS PHARMA
  • CELONIC AG
  • BIOMEVA GmbH
  • ProBioGen
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • TOYOBO CO., LTD.
  • Samsung BioLogics
  • Patheon
  • DPx
  • CMC Biologics
  • Binex Co., Ltd.
  • WuXi Biologics
  • AbbVie, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll